The Journal of Neuroscience, October 15, 2001, 21(20):7881-7888
Therapeutic Efficacy in Experimental Polyarthritis of
Viral-Driven Enkephalin Overproduction in Sensory Neurons
Joao
Braz1,
Caroline
Beaufour1,
Anne
Coutaux2,
Alberto L.
Epstein3,
François
Cesselin1,
Michel
Hamon1, and
Michel
Pohl1
1 Institut National de la Santé et de la
Recherche Médicale U288, NeuroPsychoPharmacologie
Moléculaire, Cellulaire, et Fonctionnelle and
2 Service de Rhumatologie, Hôpital
Pitié-Salpêtrière, 75013 Paris, France, and
3 Centre de Génétique Moléculaire et
Cellulaire, Centre National de la Recherche Scientifique, Unité
Mixte de Recherche 106, Université Claude Bernard Lyon 1, 69622 Villeurbanne, France
Rheumatoid arthritis is characterized by erosive inflammation of
the joints, new bone proliferation, and ankylosis, leading to severely
reduced locomotion and intense chronic pain. In a model of this
disease, adjuvant-induced polyarthritis in the rat, neurons involved in
pain transmission and control undergo plastic changes, especially at
the spinal level. These changes affect notably neurons that contain
opioids, such as enkephalins deriving from preproenkephalin A (PA)
precursor protein. Using recombinant herpes simplex virus containing
rat PA cDNA, we enhanced enkephalin synthesis in sensory neurons of
polyarthritic rats. This treatment markedly improved locomotion and
reduced hyperalgesia. Furthermore, the progression of bone destruction
slowed down, which is the most difficult target to reach in the
treatment of patients suffering from arthritis. These data demonstrate
the therapeutic efficacy of enkephalin overproduction in a model of
systemic inflammatory and painful chronic disorder.
Key words:
proenkephalin A overproduction; dorsal root sensory
ganglia neurons; polyarthritic rats; reduced hyperalgesia; improved
polyarthritis-related disability; limited joint destruction
Copyright © 2001 Society for Neuroscience 0270-6474/01/21207881-08$05.00/0